GORDON STEPHEN (Chief Financial Officer) sold 39.2% of their position (15K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $1.11M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2024ACC: 0000950170-24-040393
Officer· Chief Financial Officer
Since May 2019
-15K
Net shares
Net seller
$1.11M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
$38.46
Trade value
$576.90K
% of position
64.4%
4/1/2024
23.30K→38.30K
Common Stock
Direct
Shares
−15K
Price / share
$74.01
Trade value
$1.11M
% of position
39.2%
4/1/2024
38.30K→23.30K
Total
Net shares
+0.00
Net value
-$533.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2024 | M · Option Exercise | +15K | $38.46 | $576.90K | 64.4% | 23.30K | 38.30K |
| Common Stock Direct | 4/1/2024 | S · Sale | −15K | $74.01 | $1.11M | 39.2% | 38.30K | 23.30K |
| Total | +0.00 | -$533.25K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
38.46
Held after
37.48K
Exercisable
—
4/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 4/1/2024 | M · Option Exercise | −15K | 38.46 | — | 37.48K |